Daniel Stauder
Stock Analyst at JMP Securities
(2.45)
# 2,408
Out of 4,761 analysts
10
Total ratings
55.56%
Success rate
12.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $38.39 | +56.29% | 4 | Feb 13, 2025 | |
| AORT Artivion | Reiterates: Market Outperform | $33 | $28.26 | +16.77% | 2 | Dec 10, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Market Outperform | $77 → $100 | $99.54 | +0.46% | 3 | Aug 20, 2024 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $15.45 | - | 1 | May 7, 2024 |
AtriCure
Feb 13, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $38.39
Upside: +56.29%
Artivion
Dec 10, 2024
Reiterates: Market Outperform
Price Target: $33
Current: $28.26
Upside: +16.77%
LeMaitre Vascular
Aug 20, 2024
Maintains: Market Outperform
Price Target: $77 → $100
Current: $99.54
Upside: +0.46%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $15.45
Upside: -